Butadiene

Butadiene

SCHEMBL776313

[CH2][CH]C=C

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butadiene SCHEMBL10748476 0.71
SCHEMBL3804487 0.68
Butadiene SCHEMBL11480793 0.68 TRPA1 (0.44)
Butadiene SCHEMBL10457929 0.68 TRPA1 (0.44)
SCHEMBL192 0.68
SCHEMBL11498161 0.68
SCHEMBL17164676 0.68
Butadiene SCHEMBL11854764 0.68 TRPA1 (0.44)
Butadiene SCHEMBL461643 0.68
Butadiene SCHEMBL250 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118339156-A 2-Diazo-3-oxo-2, 3-dihydrospiro [ indene-1, 9' -xanthene ] derivatives and similar compounds as photoactive fluorescent compounds for protein labelling 爱康治疗公司 2024-07-12 CN disclosed
US-20240226132-A1 RNA COMPOSITIONS COMPRISING A BUFFER SUBSTANCE AND METHODS FOR PREPARING, STORING AND USING THE SAME BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) 2024-07-11 US disclosed
WO-2024133635-A1 COMPOSITION BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) 2024-06-27 WO disclosed
US-20240180941-A1 ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE FLAGSHIP PIONEERING INNOVATIONS V INC (US) 2024-06-06 US disclosed
EP-4377311-A1 2-DIAZO-3-OXO-2,3-DIHYDROSPIRO[INDENE-1,9'-XANTHENE] DERIVATIVES AND SIMILAR COMPOUNDS AS PHOTOACTIVE FLUORESCENT COMPOUNDS FOR PROTEIN LABELING Eikon Therapeutics Inc. (US) 2024-06-05 EP disclosed
US-11998610-B2 Conjugates and methods of using the same FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2024-06-04 US disclosed
US-11981703-B2 Polynucleotide constructs SIRIUS THERAPEUTICS, INC. (US) 2024-05-14 US disclosed
EP-4351553-A1 NOVEL ANTI-FIBROTIC DRUGS Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH (DE) 2024-04-17 EP disclosed
CN-117642185-A Improved CD30 targeting antibody drug conjugates and uses thereof 路德维希-马克西米利安慕尼黑大学 2024-03-01 CN disclosed
CN-117615752-A RNA compositions comprising buffer substances and methods of making, storing, and using the same 生物技术欧洲股份公司 2024-02-27 CN disclosed
EP-1341776-A1 BENZAZOLONYLCARBONYL CYCLOHEXENONES AND USE THEREOF AS HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 2003-09-10 EP disclosed
US-6589915-B1 The invention relates to cyclohexenone derivatives of benzo-condensed, unsaturated 5-ring nitrogen heterocycles of general formula (I) wherein X represents N or a group C-R3, Y represents O, S, SO, SO2 or NR4 or X-Y represent S BASF AKTIENGESELLSCHAFT (DE) 2003-07-08 US disclosed
WO-2003043994-A1 SUBSTITUTED ACYLAMINOPHENYLURACILS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2003-05-30 WO disclosed
US-6541423-B1 Controlling vegatation BASF AKTIENGESELLSCHAFT (DE) 2003-04-01 US disclosed
EP-0934925-B1 Process for the preparation of beta-alkoxy nitriles BASF AG (DE) 2002-09-25 EP disclosed
WO-2002048140-A1 5-[(PYRAZOL-4-YL)CARBONYL]BENZAZOLONE AS HERBICIDE BASF AKTIENGESELLSCHAFT (DE) 2002-06-20 WO disclosed
WO-2002048121-A1 BENZAZOLONYLCARBONYL CYCLOHEXENONES AND USE THEREOF AS HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 2002-06-20 WO disclosed
US-6352959-B1 HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 2002-03-05 US disclosed
EP-0934925-A1 Process for the preparation of beta-alkoxy nitriles BASF AKTIENGESELLSCHAFT (DE) 1999-08-11 EP disclosed
EP-0528762-B1 N-acyl-N-heterocyclyl- or naphthyl-alkyl amino acids as angiotensin II antagonists CIBA GEIGY AG (CH) 1997-05-07 EP disclosed